Alan Bradley

Alan Bradley

Oprichter bij
Kymab Group Ltd.
66 jaar
Health Technology
Consumer Services
Finance

Profiel

Allan Bradley is the founder of Spectral Genomics, Inc., founded in 2000.
Dr. Bradley is the founder of ExpressionEdits Ltd., founded in 2021.
Dr. Bradley is the founder of T-Therapeutics Ltd., founded in 2022, and holds the title Chief Scientific Officer & Director since 2025.
Dr. Bradley is also the founder of Lexicon Pharmaceuticals, Inc.,Kymab Group Ltd...
Dr. Bradley is an Independent Director at Sieger Healthcare Acquisition Corp.
Dr. Bradley is a Professor at the University of Cambridge.
Dr. Bradley was Executive Director at Wellcome Trust Sanger Institute.
Dr. Bradley was Professor at Baylor College of Medicine.
Dr. Bradley completed undergraduate, graduate, and doctorate degrees at the University of Cambridge.

Actieve functies van Alan Bradley

BedrijvenFunctieBegin
Directeur/Bestuurslid -
Oprichter -
Corporate Officer/Principal -

Eerdere bekende functies van Alan Bradley

BedrijvenFunctieEinde
Oprichter -
Corporate Officer/Principal -
LEXICON PHARMACEUTICALS, INC. Oprichter -
Directeur/Bestuurslid -
Oprichter -
Ervaring van Alan Bradley in detail bekijken

Opleiding van Alan Bradley

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

91

Eerstegraads connecties

8

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit8

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Commercial Services

  1. Beurs
  2. Insiders
  3. Alan Bradley